Legacy Education (LGCY) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Achieved record Q3 2025 with 50.7% revenue growth to $18.6 million and a 49.8% increase in enrollment to 3,245 students, driven by strong demand, strategic focus, and the acquisition of Contra Costa Medical Career College (CCMCC), which contributed 468 students.
Net income for Q3 2025 rose to $2.8 million, with adjusted EBITDA of $3.9 million and diluted EPS of $0.21; for the nine months ended March 31, 2025, net income was $6.3 million and diluted EPS was $0.51.
Completed IPO in September 2024, raising $10 million plus $1.5 million from an over-allotment option, and implemented a 1-for-2 reverse stock split.
Maintained high educational outcomes, including an 83% nursing NCLEX pass rate and placement rates of 75% and 76%.
Operates six nationally accredited campuses in California, focusing on allied healthcare, veterinary, and business programs.
Financial highlights
Q3 2025 revenue reached $18.6 million, up 50.7% year-over-year; nine-month revenue was $46.2 million, up 39% year-over-year.
Net income for the nine months ended March 31, 2025 was $6.3 million, up from $4.2 million in the prior-year period.
Adjusted EBITDA for Q3 was $3.9 million, and for the last twelve months was $11.4 million, a 170% increase year-over-year.
Cash and cash equivalents stood at $17.3 million as of March 31, 2025, with $22 million in working capital and minimal debt of $1 million.
Student acquisition cost for Q3 2025 was $1,000, with annual revenue per student at $22,000.
Outlook and guidance
Strategic priorities include driving enrollment growth, expanding program offerings, optimizing operational efficiency, and pursuing accretive acquisitions.
Management expects continued strong enrollment trends and sufficient liquidity for ongoing operations and planned capital expenditures for at least the next 12 months.
New programs in sterile processing, surgical technician, and EMT are being launched.
Seasonality expected to impact Q4, with Q1 and Q3 typically being the strongest quarters.
Management expects to leverage scale and efficiencies to sustain profitability.
Latest events from Legacy Education
- Q2 revenue up 40.7% and net income up 46%, driven by enrollment and acquisition growth.LGCY
Q2 20268 Jul 2026 - Q3 2026 revenue up 15% and net income up 7.5%, driven by enrollment and new programs.LGCY
Q3 202614 May 2026 - Achieved 42% revenue growth and 17% enrollment growth, with strong student outcomes and robust liquidity.LGCY
Investor presentation20 Mar 2026 - Achieved 40% revenue growth and 38% enrollment increase, driven by healthcare-focused programs and acquisitions.LGCY
Investor presentation12 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025